Global Sorafenib Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Date : Oct 2018

Formats :
Report Code : PMR103807792

Category : Pharmaceutical and Healthcare
No Of Pages : 111

Sorafenib Market



Scope of the Report:

This report focuses on the Sorafenib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Sorafenib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new Planet Market Reports study.



Market Segment by Manufacturers, this report covers

Bayer

Natco Pharma

Cipla

Mylan



Market Segment by Regions, regional analysis covers

North America United States, Canada and Mexico

Europe Germany, France, UK, Russia and Italy

Asia-Pacific China, Japan, Korea, India and Southeast Asia

South America Brazil, Argentina, Colombia etc.

Middle East and Africa Saudi Arabia, UAE, Egypt, Nigeria and South Africa



Market Segment by Type, covers

Patented Drugs

Generic Drugs



Market Segment by Applications, can be divided into

Kidney Cancer

Liver Cancer

Thyroid Cancer

Other



There are 15 Chapters to deeply display the global Sorafenib market.

Chapter 1, to describe Sorafenib Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Sorafenib, with sales, revenue, and price of Sorafenib, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Sorafenib, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Sorafenib market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Sorafenib sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents



1 Market Overview

1.1 Sorafenib Introduction

1.2 Market Analysis by Type

1.2.1 Patented Drugs

1.2.2 Generic Drugs

1.3 Market Analysis by Applications

1.3.1 Kidney Cancer

1.3.2 Liver Cancer

1.3.3 Thyroid Cancer

1.3.4 Other

1.4 Market Analysis by Regions

1.4.1 North America United States, Canada and Mexico

1.4.1.1 United States Market States and Outlook 2013-2023

1.4.1.2 Canada Market States and Outlook 2013-2023

1.4.1.3 Mexico Market States and Outlook 2013-2023

1.4.2 Europe Germany, France, UK, Russia and Italy

1.4.2.1 Germany Market States and Outlook 2013-2023

1.4.2.2 France Market States and Outlook 2013-2023

1.4.2.3 UK Market States and Outlook 2013-2023

1.4.2.4 Russia Market States and Outlook 2013-2023

1.4.2.5 Italy Market States and Outlook 2013-2023

1.4.3 Asia-Pacific China, Japan, Korea, India and Southeast Asia

1.4.3.1 China Market States and Outlook 2013-2023

1.4.3.2 Japan Market States and Outlook 2013-2023

1.4.3.3 Korea Market States and Outlook 2013-2023

1.4.3.4 India Market States and Outlook 2013-2023

1.4.3.5 Southeast Asia Market States and Outlook 2013-2023

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook 2013-2023

1.4.4.2 Egypt Market States and Outlook 2013-2023

1.4.4.3 Saudi Arabia Market States and Outlook 2013-2023

1.4.4.4 South Africa Market States and Outlook 2013-2023

1.4.4.5 Nigeria Market States and Outlook 2013-2023

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Bayer

2.1.1 Business Overview

2.1.2 Sorafenib Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bayer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.2 Natco Pharma

2.2.1 Business Overview

2.2.2 Sorafenib Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Natco Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.3 Cipla

2.3.1 Business Overview

2.3.2 Sorafenib Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Cipla Sorafenib Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.4 Mylan

2.4.1 Business Overview

2.4.2 Sorafenib Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Mylan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

3 Global Sorafenib Sales, Revenue, Market Share and Competition by Manufacturer 2016-2017

3.1 Global Sorafenib Sales and Market Share by Manufacturer 2016-2017

3.2 Global Sorafenib Revenue and Market Share by Manufacturer 2016-2017

3.3 Market Concentration Rate

3.3.1 Top 3 Sorafenib Manufacturer Market Share in 2017

3.3.2 Top 6 Sorafenib Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Sorafenib Market Analysis by Regions

4.1 Global Sorafenib Sales, Revenue and Market Share by Regions

4.1.1 Global Sorafenib Sales and Market Share by Regions 2013-2018

4.1.2 Global Sorafenib Revenue and Market Share by Regions 2013-2018

4.2 North America Sorafenib Sales and Growth Rate 2013-2018

4.3 Europe Sorafenib Sales and Growth Rate 2013-2018

4.4 Asia-Pacific Sorafenib Sales and Growth Rate 2013-2018

4.5 South America Sorafenib Sales and Growth Rate 2013-2018

4.6 Middle East and Africa Sorafenib Sales and Growth Rate 2013-2018

5 North America Sorafenib by Countries

5.1 North America Sorafenib Sales, Revenue and Market Share by Countries

5.1.1 North America Sorafenib Sales and Market Share by Countries 2013-2018

5.1.2 North America Sorafenib Revenue and Market Share by Countries 2013-2018

5.2 United States Sorafenib Sales and Growth Rate 2013-2018

5.3 Canada Sorafenib Sales and Growth Rate 2013-2018

5.4 Mexico Sorafenib Sales and Growth Rate 2013-2018

6 Europe Sorafenib by Countries

6.1 Europe Sorafenib Sales, Revenue and Market Share by Countries

6.1.1 Europe Sorafenib Sales and Market Share by Countries 2013-2018

6.1.2 Europe Sorafenib Revenue and Market Share by Countries 2013-2018

6.2 Germany Sorafenib Sales and Growth Rate 2013-2018

6.3 UK Sorafenib Sales and Growth Rate 2013-2018

6.4 France Sorafenib Sales and Growth Rate 2013-2018

6.5 Russia Sorafenib Sales and Growth Rate 2013-2018

6.6 Italy Sorafenib Sales and Growth Rate 2013-2018

7 Asia-Pacific Sorafenib by Countries

7.1 Asia-Pacific Sorafenib Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Sorafenib Sales and Market Share by Countries 2013-2018

7.1.2 Asia-Pacific Sorafenib Revenue and Market Share by Countries 2013-2018

7.2 China Sorafenib Sales and Growth Rate 2013-2018

7.3 Japan Sorafenib Sales and Growth Rate 2013-2018

7.4 Korea Sorafenib Sales and Growth Rate 2013-2018

7.5 India Sorafenib Sales and Growth Rate 2013-2018

7.6 Southeast Asia Sorafenib Sales and Growth Rate 2013-2018

8 South America Sorafenib by Countries

8.1 South America Sorafenib Sales, Revenue and Market Share by Countries

8.1.1 South America Sorafenib Sales and Market Share by Countries 2013-2018

8.1.2 South America Sorafenib Revenue and Market Share by Countries 2013-2018

8.2 Brazil Sorafenib Sales and Growth Rate 2013-2018

8.3 Argentina Sorafenib Sales and Growth Rate 2013-2018

8.4 Colombia Sorafenib Sales and Growth Rate 2013-2018

9 Middle East and Africa Sorafenib by Countries

9.1 Middle East and Africa Sorafenib Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Sorafenib Sales and Market Share by Countries 2013-2018

9.1.2 Middle East and Africa Sorafenib Revenue and Market Share by Countries 2013-2018

9.2 Saudi Arabia Sorafenib Sales and Growth Rate 2013-2018

9.3 UAE Sorafenib Sales and Growth Rate 2013-2018

9.4 Egypt Sorafenib Sales and Growth Rate 2013-2018

9.5 Nigeria Sorafenib Sales and Growth Rate 2013-2018

9.6 South Africa Sorafenib Sales and Growth Rate 2013-2018

10 Global Sorafenib Market Segment by Type

10.1 Global Sorafenib Sales, Revenue and Market Share by Type 2013-2018

10.1.1 Global Sorafenib Sales and Market Share by Type 2013-2018

10.1.2 Global Sorafenib Revenue and Market Share by Type 2013-2018

10.2 Patented Drugs Sales Growth and Price

10.2.1 Global Patented Drugs Sales Growth 2013-2018

10.2.2 Global Patented Drugs Price 2013-2018

10.3 Generic Drugs Sales Growth and Price

10.3.1 Global Generic Drugs Sales Growth 2013-2018

10.3.2 Global Generic Drugs Price 2013-2018

11 Global Sorafenib Market Segment by Application

11.1 Global Sorafenib Sales Market Share by Application 2013-2018

11.2 Kidney Cancer Sales Growth 2013-2018

11.3 Liver Cancer Sales Growth 2013-2018

11.4 Thyroid Cancer Sales Growth 2013-2018

11.5 Other Sales Growth 2013-2018

12 Sorafenib Market Forecast 2018-2023

12.1 Global Sorafenib Sales, Revenue and Growth Rate 2018-2023

12.2 Sorafenib Market Forecast by Regions 2018-2023

12.2.1 North America Sorafenib Market Forecast 2018-2023

12.2.2 Europe Sorafenib Market Forecast 2018-2023

12.2.3 Asia-Pacific Sorafenib Market Forecast 2018-2023

12.2.4 South America Sorafenib Market Forecast 2018-2023

12.2.5 Middle East and Africa Sorafenib Market Forecast 2018-2023

12.3 Sorafenib Market Forecast by Type 2018-2023

12.3.1 Global Sorafenib Sales Forecast by Type 2018-2023

12.3.2 Global Sorafenib Market Share Forecast by Type 2018-2023

12.4 Sorafenib Market Forecast by Application 2018-2023

12.4.1 Global Sorafenib Sales Forecast by Application 2018-2023

12.4.2 Global Sorafenib Market Share Forecast by Application 2018-2023

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source
List of Tables and Figures



Figure Sorafenib Picture

Table Product Specifications of Sorafenib

Figure Global Sales Market Share of Sorafenib by Types in 2017

Table Sorafenib Types for Major Manufacturers

Figure Patented Drugs Picture

Figure Generic Drugs Picture

Figure Sorafenib Sales Market Share by Applications in 2017

Figure Kidney Cancer Picture

Figure Liver Cancer Picture

Figure Thyroid Cancer Picture

Figure Other Picture

Figure United States Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure France Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure UK Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure China Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure India Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Sorafenib Revenue (Value) and Growth Rate (2013-2023)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Sorafenib Type and Applications

Table Bayer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Natco Pharma Basic Information, Manufacturing Base and Competitors

Table Natco Pharma Sorafenib Type and Applications

Table Natco Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Sorafenib Type and Applications

Table Cipla Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Sorafenib Type and Applications

Table Mylan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Sorafenib Sales by Manufacturer (2016-2017)

Figure Global Sorafenib Sales Market Share by Manufacturer in 2016

Figure Global Sorafenib Sales Market Share by Manufacturer in 2017

Table Global Sorafenib Revenue by Manufacturer (2016-2017)

Figure Global Sorafenib Revenue Market Share by Manufacturer in 2016

Figure Global Sorafenib Revenue Market Share by Manufacturer in 2017

Figure Top 3 Sorafenib Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Sorafenib Manufacturer (Revenue) Market Share in 2017

Figure Global Sorafenib Sales and Growth Rate (2013-2018)

Figure Global Sorafenib Revenue and Growth Rate (2013-2018)

Table Global Sorafenib Sales by Regions (2013-2018)

Table Global Sorafenib Sales Market Share by Regions (2013-2018)

Table Global Sorafenib Revenue by Regions (2013-2018)

Figure Global Sorafenib Revenue Market Share by Regions in 2013

Figure Global Sorafenib Revenue Market Share by Regions in 2017

Figure North America Sorafenib Sales and Growth Rate (2013-2018)

Figure Europe Sorafenib Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Sorafenib Sales and Growth Rate (2013-2018)

Figure South America Sorafenib Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Sorafenib Sales and Growth Rate (2013-2018)

Figure North America Sorafenib Revenue and Growth Rate (2013-2018)

Table North America Sorafenib Sales by Countries (2013-2018)

Table North America Sorafenib Sales Market Share by Countries (2013-2018)

Figure North America Sorafenib Sales Market Share by Countries in 2013

Figure North America Sorafenib Sales Market Share by Countries in 2017

Table North America Sorafenib Revenue by Countries (2013-2018)

Table North America Sorafenib Revenue Market Share by Countries (2013-2018)

Figure North America Sorafenib Revenue Market Share by Countries in 2013

Figure North America Sorafenib Revenue Market Share by Countries in 2017

Figure United States Sorafenib Sales and Growth Rate (2013-2018)

Figure Canada Sorafenib Sales and Growth Rate (2013-2018)

Figure Mexico Sorafenib Sales and Growth Rate (2013-2018)

Figure Europe Sorafenib Revenue and Growth Rate (2013-2018)

Table Europe Sorafenib Sales by Countries (2013-2018)

Table Europe Sorafenib Sales Market Share by Countries (2013-2018)

Table Europe Sorafenib Revenue by Countries (2013-2018)

Figure Europe Sorafenib Revenue Market Share by Countries in 2016

Figure Europe Sorafenib Revenue Market Share by Countries in 2017

Figure Germany Sorafenib Sales and Growth Rate (2013-2018)

Figure UK Sorafenib Sales and Growth Rate (2013-2018)

Figure France Sorafenib Sales and Growth Rate (2013-2018)

Figure Russia Sorafenib Sales and Growth Rate (2013-2018)

Figure Italy Sorafenib Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Sorafenib Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Sorafenib Sales by Countries (2013-2018)

Table Asia-Pacific Sorafenib Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Sorafenib Sales Market Share by Countries 2017

Table Asia-Pacific Sorafenib Revenue by Countries (2013-2018)

Figure Asia-Pacific Sorafenib Revenue Market Share by Countries 2017

Figure China Sorafenib Sales and Growth Rate (2013-2018)

Figure Japan Sorafenib Sales and Growth Rate (2013-2018)

Figure Korea Sorafenib Sales and Growth Rate (2013-2018)

Figure India Sorafenib Sales and Growth Rate (2013-2018)

Figure Southeast Asia Sorafenib Sales and Growth Rate (2013-2018)

Figure South America Sorafenib Revenue and Growth Rate (2013-2018)

Table South America Sorafenib Sales by Countries (2013-2018)

Table South America Sorafenib Sales Market Share by Countries (2013-2018)

Figure South America Sorafenib Sales Market Share by Countries in 2017

Table South America Sorafenib Revenue by Countries (2013-2018)

Table South America Sorafenib Revenue Market Share by Countries (2013-2018)

Figure South America Sorafenib Revenue Market Share by Countries in 2017

Figure Brazil Sorafenib Sales and Growth Rate (2013-2018)

Figure Argentina Sorafenib Sales and Growth Rate (2013-2018)

Figure Colombia Sorafenib Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Sorafenib Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Sorafenib Sales by Countries (2013-2018)

Table Middle East and Africa Sorafenib Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Sorafenib Sales Market Share by Countries in 2017

Table Middle East and Africa Sorafenib Revenue by Countries (2013-2018)

Table Middle East and Africa Sorafenib Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Sorafenib Revenue Market Share by Countries in 2013

Figure Middle East and Africa Sorafenib Revenue Market Share by Countries in 2017

Figure Saudi Arabia Sorafenib Sales and Growth Rate (2013-2018)

Figure UAE Sorafenib Sales and Growth Rate (2013-2018)

Figure Egypt Sorafenib Sales and Growth Rate (2013-2018)

Figure Nigeria Sorafenib Sales and Growth Rate (2013-2018)

Figure South Africa Sorafenib Sales and Growth Rate (2013-2018)

Table Global Sorafenib Sales by Type (2013-2018)

Table Global Sorafenib Sales Share by Type (2013-2018)

Table Global Sorafenib Revenue by Type (2013-2018)

Table Global Sorafenib Revenue Share by Type (2013-2018)

Figure Global Patented Drugs Sales Growth (2013-2018)

Figure Global Patented Drugs Price (2013-2018)

Figure Global Generic Drugs Sales Growth (2013-2018)

Figure Global Generic Drugs Price (2013-2018)

Table Global Sorafenib Sales by Application (2013-2018)

Table Global Sorafenib Sales Share by Application (2013-2018)

Figure Global Liver Cancer Sales Growth (2013-2018)

Figure Global Thyroid Cancer Sales Growth (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Sorafenib Sales, Revenue and Growth Rate (2018-2023)

Table Global Sorafenib Sales Forecast by Regions (2018-2023)

Table Global Sorafenib Market Share Forecast by Regions (2018-2023)

Figure North America Sales Sorafenib Market Forecast (2018-2023)

Figure Europe Sales Sorafenib Market Forecast (2018-2023)

Figure Asia-Pacific Sales Sorafenib Market Forecast (2018-2023)

Figure South America Sales Sorafenib Market Forecast (2018-2023)

Figure Middle East and Africa Sales Sorafenib Market Forecast (2018-2023)

Table Global Sorafenib Sales Forecast by Type (2018-2023)

Table Global Sorafenib Market Share Forecast by Type (2018-2023)

Table Global Sorafenib Sales Forecast by Application (2018-2023)

Table Global Sorafenib Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to choose PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....

About Report

Planet Market Reports added Latest and detailed market study report that focuses on “Global Sorafenib Market" Which offers essential information based on fresh ideas into Global Sorafenib Market industry along with unique market analysis which covers current top Manufactures in Global Sorafenib Market, growth, Consumption Demand, challenges, Historical data, subjects wise Survey of each chapters, Regional Insights, and Advancing industry trends, which will help our clients to aim Global Sorafenib Market. In addition, the report helps the customers to get a brief idea about Future demand and specifications of products which ensures the driving long-term income and productivity of global market.